Abstract - J Cardiothorac Vasc Anesth 1997 Jun;11(4):440-4

Continuous intraoperative noninvasive cardiac output monitoring using a new thoracic bioimpedance device.

Thangathurai D; Charbonnet C; Roessler P; Wo CC; Mikhail M; Yoahida R; Shoemaker WC Department of Anesthesiology, University of Southern California School of Medicine, Los Angeles, USA.

OBJECTIVES: To compare a new noninvasive bioimpedance device with the standard thermodilution method during the intraoperative period in high-risk patients undergoing oncological surgery.

DESIGN: Prospectively collected data with retrospective analysis.

SETTING: The study was undertaken at a university hospital, single institution.

PARTICIPANTS: Twenty-three selected adults undergoing extensive, ablative oncological surgery.

INTERVENTIONS: Simultaneous measurements of cardiac output by a new bioimpedance method and the standard thermodilution method during the intraoperative and immediate postoperative periods.

MEASUREMENTS AND MAIN RESULTS: The correlation coefficient between the two methods was r = 0.89, p < 0.001. Bias and precision analysis between the two techniques showed a mean bias of 0.1 L/min and SD of the bias [precision] of 1.0 L/min [95% level of agreement +2.1 L/min to -1.9 L/min]. After software enhancement, data from the last 11 monitored patients showed improved correlation between the two methods; r = 0.93, mean bias -0.1 L/min, and precision 0.8 L/min. Electrical and motion-induced interference only transiently impaired the performance of the new impedance method.

CONCLUSION: This new impedance device is a safe, reliable, clinically acceptable alternative to the invasive thermodilution method in the operating room environment.


 
  RETURN TO ABSTRACT INDEX
Company | Products | Patient Monitoring | Clinical Trials | Corporate Relations | Abstract/Case Studies | News | Contact
©2008, All Rights Reserved, NMT, Inc. | ETag™, IQ2™ and NcIQ™ are not yet FDA approved for sale